nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—ALB—Crohn's disease	0.373	1	CbGaD
Amitriptyline—HTR7—enteric nervous system—Crohn's disease	0.0203	0.123	CbGeAlD
Amitriptyline—HTR7—myenteric nerve plexus—Crohn's disease	0.0154	0.0929	CbGeAlD
Amitriptyline—ORM1—bile—Crohn's disease	0.0147	0.0891	CbGeAlD
Amitriptyline—CHRM3—muscle of abdomen—Crohn's disease	0.0135	0.0816	CbGeAlD
Amitriptyline—HTR2A—enteric nervous system—Crohn's disease	0.0127	0.0765	CbGeAlD
Amitriptyline—NTRK2—mouth—Crohn's disease	0.0115	0.0697	CbGeAlD
Amitriptyline—HTR2A—myenteric nerve plexus—Crohn's disease	0.00959	0.058	CbGeAlD
Amitriptyline—CYP3A5—Sulfasalazine—Crohn's disease	0.00858	0.288	CbGbCtD
Amitriptyline—ALB—Prednisone—Crohn's disease	0.00854	0.287	CbGbCtD
Amitriptyline—Lupus-like syndrome—Mesalazine—Crohn's disease	0.00835	0.0618	CcSEcCtD
Amitriptyline—CYP2C19—Prednisone—Crohn's disease	0.00554	0.186	CbGbCtD
Amitriptyline—Bone marrow depression—Mercaptopurine—Crohn's disease	0.00537	0.0397	CcSEcCtD
Amitriptyline—ABCB1—Prednisone—Crohn's disease	0.00447	0.15	CbGbCtD
Amitriptyline—ORM1—gall bladder—Crohn's disease	0.00409	0.0247	CbGeAlD
Amitriptyline—Tongue discolouration—Mesalazine—Crohn's disease	0.00407	0.0301	CcSEcCtD
Amitriptyline—ALB—gall bladder—Crohn's disease	0.00359	0.0217	CbGeAlD
Amitriptyline—Bone marrow depression—Azathioprine—Crohn's disease	0.0032	0.0237	CcSEcCtD
Amitriptyline—Bone marrow depression—Mesalazine—Crohn's disease	0.00292	0.0216	CcSEcCtD
Amitriptyline—NTRK2—lymph node—Crohn's disease	0.00292	0.0176	CbGeAlD
Amitriptyline—CHRM5—epithelium—Crohn's disease	0.00288	0.0174	CbGeAlD
Amitriptyline—HRH2—skin of body—Crohn's disease	0.00286	0.0173	CbGeAlD
Amitriptyline—CHRM5—skin of body—Crohn's disease	0.00274	0.0165	CbGeAlD
Amitriptyline—CYP3A4—Prednisone—Crohn's disease	0.00268	0.0898	CbGbCtD
Amitriptyline—HTR7—mouth—Crohn's disease	0.00263	0.0159	CbGeAlD
Amitriptyline—ADRA1D—epithelium—Crohn's disease	0.00257	0.0155	CbGeAlD
Amitriptyline—Withdrawal symptom—Prednisone—Crohn's disease	0.00254	0.0188	CcSEcCtD
Amitriptyline—Intraocular pressure increased—Prednisone—Crohn's disease	0.00237	0.0175	CcSEcCtD
Amitriptyline—HRH2—digestive system—Crohn's disease	0.00229	0.0138	CbGeAlD
Amitriptyline—Pancytopenia—Mercaptopurine—Crohn's disease	0.00216	0.016	CcSEcCtD
Amitriptyline—Drug withdrawal syndrome—Prednisone—Crohn's disease	0.00212	0.0157	CcSEcCtD
Amitriptyline—Stomatitis—Mercaptopurine—Crohn's disease	0.00198	0.0146	CcSEcCtD
Amitriptyline—Coma—Mesalazine—Crohn's disease	0.0018	0.0133	CcSEcCtD
Amitriptyline—Hepatic failure—Azathioprine—Crohn's disease	0.00175	0.0129	CcSEcCtD
Amitriptyline—SIGMAR1—smooth muscle tissue—Crohn's disease	0.00173	0.0104	CbGeAlD
Amitriptyline—KCND3—lymph node—Crohn's disease	0.00168	0.0101	CbGeAlD
Amitriptyline—Alopecia—Mercaptopurine—Crohn's disease	0.00161	0.0119	CcSEcCtD
Amitriptyline—Disorientation—Mesalazine—Crohn's disease	0.0016	0.0118	CcSEcCtD
Amitriptyline—Hepatic failure—Mesalazine—Crohn's disease	0.00159	0.0118	CcSEcCtD
Amitriptyline—SIGMAR1—mammalian vulva—Crohn's disease	0.00155	0.00939	CbGeAlD
Amitriptyline—CHRM3—smooth muscle tissue—Crohn's disease	0.00155	0.00936	CbGeAlD
Amitriptyline—Libido decreased—Mesalazine—Crohn's disease	0.00154	0.0114	CcSEcCtD
Amitriptyline—HTR7—epithelium—Crohn's disease	0.00153	0.00925	CbGeAlD
Amitriptyline—ADRA1A—epithelium—Crohn's disease	0.00148	0.00892	CbGeAlD
Amitriptyline—HTR7—smooth muscle tissue—Crohn's disease	0.00147	0.00891	CbGeAlD
Amitriptyline—Delusion—Prednisone—Crohn's disease	0.00147	0.0109	CcSEcCtD
Amitriptyline—Arthritis—Mesalazine—Crohn's disease	0.00147	0.0109	CcSEcCtD
Amitriptyline—Mania—Prednisone—Crohn's disease	0.00143	0.0106	CcSEcCtD
Amitriptyline—Osteoarthritis—Mesalazine—Crohn's disease	0.00143	0.0106	CcSEcCtD
Amitriptyline—Leukopenia—Mercaptopurine—Crohn's disease	0.00142	0.0105	CcSEcCtD
Amitriptyline—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.00142	0.0105	CcSEcCtD
Amitriptyline—SLC6A4—digestive system—Crohn's disease	0.00137	0.00829	CbGeAlD
Amitriptyline—HRH2—lymph node—Crohn's disease	0.00131	0.00791	CbGeAlD
Amitriptyline—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00131	0.00965	CcSEcCtD
Amitriptyline—Oedema—Mercaptopurine—Crohn's disease	0.00129	0.00957	CcSEcCtD
Amitriptyline—Pancytopenia—Azathioprine—Crohn's disease	0.00129	0.00952	CcSEcCtD
Amitriptyline—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00127	0.00937	CcSEcCtD
Amitriptyline—Anorexia—Mercaptopurine—Crohn's disease	0.00123	0.00912	CcSEcCtD
Amitriptyline—CHRM3—digestive system—Crohn's disease	0.00122	0.00739	CbGeAlD
Amitriptyline—Eosinophilia—Mesalazine—Crohn's disease	0.00122	0.00905	CcSEcCtD
Amitriptyline—Pancytopenia—Mesalazine—Crohn's disease	0.00117	0.00868	CcSEcCtD
Amitriptyline—HTR7—digestive system—Crohn's disease	0.00116	0.00704	CbGeAlD
Amitriptyline—HRH1—epithelium—Crohn's disease	0.00114	0.00691	CbGeAlD
Amitriptyline—Pollakiuria—Mesalazine—Crohn's disease	0.00114	0.00844	CcSEcCtD
Amitriptyline—CYP2C19—digestive system—Crohn's disease	0.00114	0.00687	CbGeAlD
Amitriptyline—ADRA1A—lymphoid tissue—Crohn's disease	0.00114	0.00687	CbGeAlD
Amitriptyline—Agranulocytosis—Azathioprine—Crohn's disease	0.00113	0.00835	CcSEcCtD
Amitriptyline—Decreased appetite—Mercaptopurine—Crohn's disease	0.00112	0.00832	CcSEcCtD
Amitriptyline—Weight increased—Mesalazine—Crohn's disease	0.00112	0.00831	CcSEcCtD
Amitriptyline—CYP2B6—skin of body—Crohn's disease	0.00111	0.00673	CbGeAlD
Amitriptyline—HRH1—smooth muscle tissue—Crohn's disease	0.0011	0.00665	CbGeAlD
Amitriptyline—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00108	0.00798	CcSEcCtD
Amitriptyline—Jaundice—Mesalazine—Crohn's disease	0.00107	0.00794	CcSEcCtD
Amitriptyline—Stomatitis—Mesalazine—Crohn's disease	0.00107	0.00794	CcSEcCtD
Amitriptyline—Desipramine—SLC22A4—Crohn's disease	0.00106	0.211	CrCbGaD
Amitriptyline—Agranulocytosis—Mesalazine—Crohn's disease	0.00103	0.0076	CcSEcCtD
Amitriptyline—Body temperature increased—Mercaptopurine—Crohn's disease	0.00102	0.00757	CcSEcCtD
Amitriptyline—HRH1—mammalian vulva—Crohn's disease	0.000991	0.00599	CbGeAlD
Amitriptyline—Hepatitis—Mesalazine—Crohn's disease	0.000989	0.00731	CcSEcCtD
Amitriptyline—ADRA2A—mammalian vulva—Crohn's disease	0.000974	0.00588	CbGeAlD
Amitriptyline—Arrhythmia—Azathioprine—Crohn's disease	0.000969	0.00717	CcSEcCtD
Amitriptyline—Alopecia—Azathioprine—Crohn's disease	0.000959	0.00709	CcSEcCtD
Amitriptyline—HTR2A—epithelium—Crohn's disease	0.000955	0.00577	CbGeAlD
Amitriptyline—CYP1A2—digestive system—Crohn's disease	0.000929	0.00561	CbGeAlD
Amitriptyline—Tinnitus—Mesalazine—Crohn's disease	0.000922	0.00682	CcSEcCtD
Amitriptyline—ORM1—lymph node—Crohn's disease	0.00092	0.00556	CbGeAlD
Amitriptyline—HTR2A—smooth muscle tissue—Crohn's disease	0.00092	0.00556	CbGeAlD
Amitriptyline—Imipramine—SLC22A4—Crohn's disease	0.000903	0.179	CrCbGaD
Amitriptyline—CYP2B6—lymphoid tissue—Crohn's disease	0.000901	0.00545	CbGeAlD
Amitriptyline—Diphenhydramine—SLC22A5—Crohn's disease	0.000899	0.178	CrCbGaD
Amitriptyline—CYP3A5—digestive system—Crohn's disease	0.000896	0.00541	CbGeAlD
Amitriptyline—CYP2B6—digestive system—Crohn's disease	0.00089	0.00538	CbGeAlD
Amitriptyline—Diarrhoea—Mercaptopurine—Crohn's disease	0.000885	0.00655	CcSEcCtD
Amitriptyline—CYP2C9—digestive system—Crohn's disease	0.000882	0.00533	CbGeAlD
Amitriptyline—Ill-defined disorder—Azathioprine—Crohn's disease	0.000877	0.00648	CcSEcCtD
Amitriptyline—Alopecia—Mesalazine—Crohn's disease	0.000873	0.00646	CcSEcCtD
Amitriptyline—HRH1—digestive system—Crohn's disease	0.000869	0.00525	CbGeAlD
Amitriptyline—Malaise—Azathioprine—Crohn's disease	0.000852	0.0063	CcSEcCtD
Amitriptyline—CYP2E1—lymphoid tissue—Crohn's disease	0.000846	0.00511	CbGeAlD
Amitriptyline—Leukopenia—Azathioprine—Crohn's disease	0.000846	0.00626	CcSEcCtD
Amitriptyline—Vascular purpura—Prednisone—Crohn's disease	0.000845	0.00625	CcSEcCtD
Amitriptyline—Dysgeusia—Mesalazine—Crohn's disease	0.000843	0.00623	CcSEcCtD
Amitriptyline—CYP2E1—digestive system—Crohn's disease	0.000836	0.00505	CbGeAlD
Amitriptyline—Vomiting—Mercaptopurine—Crohn's disease	0.000823	0.00609	CcSEcCtD
Amitriptyline—Rash—Mercaptopurine—Crohn's disease	0.000816	0.00604	CcSEcCtD
Amitriptyline—Dermatitis—Mercaptopurine—Crohn's disease	0.000815	0.00603	CcSEcCtD
Amitriptyline—Vision blurred—Mesalazine—Crohn's disease	0.000811	0.006	CcSEcCtD
Amitriptyline—ALB—lymph node—Crohn's disease	0.000807	0.00487	CbGeAlD
Amitriptyline—Tremor—Mesalazine—Crohn's disease	0.000806	0.00596	CcSEcCtD
Amitriptyline—Desipramine—SLC22A5—Crohn's disease	0.0008	0.159	CrCbGaD
Amitriptyline—Ill-defined disorder—Mesalazine—Crohn's disease	0.000798	0.00591	CcSEcCtD
Amitriptyline—Discomfort—Azathioprine—Crohn's disease	0.000795	0.00588	CcSEcCtD
Amitriptyline—Purpura—Prednisone—Crohn's disease	0.000784	0.0058	CcSEcCtD
Amitriptyline—SIGMAR1—lymph node—Crohn's disease	0.000779	0.0047	CbGeAlD
Amitriptyline—Malaise—Mesalazine—Crohn's disease	0.000776	0.00574	CcSEcCtD
Amitriptyline—Syncope—Mesalazine—Crohn's disease	0.000772	0.00571	CcSEcCtD
Amitriptyline—Leukopenia—Mesalazine—Crohn's disease	0.00077	0.0057	CcSEcCtD
Amitriptyline—Nausea—Mercaptopurine—Crohn's disease	0.000769	0.00569	CcSEcCtD
Amitriptyline—Palpitations—Mesalazine—Crohn's disease	0.00076	0.00563	CcSEcCtD
Amitriptyline—Loss of consciousness—Mesalazine—Crohn's disease	0.000756	0.00559	CcSEcCtD
Amitriptyline—Osteoarthritis—Prednisone—Crohn's disease	0.000756	0.00559	CcSEcCtD
Amitriptyline—Thrombocytopenia—Azathioprine—Crohn's disease	0.000755	0.00558	CcSEcCtD
Amitriptyline—Hypertension—Mesalazine—Crohn's disease	0.000743	0.0055	CcSEcCtD
Amitriptyline—Anxiety—Mesalazine—Crohn's disease	0.00073	0.0054	CcSEcCtD
Amitriptyline—HTR2A—digestive system—Crohn's disease	0.000726	0.00439	CbGeAlD
Amitriptyline—Discomfort—Mesalazine—Crohn's disease	0.000724	0.00535	CcSEcCtD
Amitriptyline—Irritability—Prednisone—Crohn's disease	0.000722	0.00534	CcSEcCtD
Amitriptyline—Hypotension—Azathioprine—Crohn's disease	0.00072	0.00533	CcSEcCtD
Amitriptyline—Dry mouth—Mesalazine—Crohn's disease	0.000716	0.0053	CcSEcCtD
Amitriptyline—Confusional state—Mesalazine—Crohn's disease	0.000708	0.00524	CcSEcCtD
Amitriptyline—Oedema—Mesalazine—Crohn's disease	0.000702	0.0052	CcSEcCtD
Amitriptyline—Shock—Mesalazine—Crohn's disease	0.000691	0.00511	CcSEcCtD
Amitriptyline—SLC6A2—lymph node—Crohn's disease	0.00069	0.00417	CbGeAlD
Amitriptyline—Thrombocytopenia—Mesalazine—Crohn's disease	0.000688	0.00509	CcSEcCtD
Amitriptyline—Tachycardia—Mesalazine—Crohn's disease	0.000685	0.00507	CcSEcCtD
Amitriptyline—Hyperhidrosis—Mesalazine—Crohn's disease	0.000679	0.00502	CcSEcCtD
Amitriptyline—CYP3A4—digestive system—Crohn's disease	0.000672	0.00406	CbGeAlD
Amitriptyline—Anorexia—Mesalazine—Crohn's disease	0.000669	0.00495	CcSEcCtD
Amitriptyline—CYP2D6—digestive system—Crohn's disease	0.000662	0.004	CbGeAlD
Amitriptyline—Hypotension—Mesalazine—Crohn's disease	0.000656	0.00485	CcSEcCtD
Amitriptyline—Sweating increased—Prednisone—Crohn's disease	0.000636	0.00471	CcSEcCtD
Amitriptyline—Feeling abnormal—Azathioprine—Crohn's disease	0.000635	0.0047	CcSEcCtD
Amitriptyline—Insomnia—Mesalazine—Crohn's disease	0.000635	0.0047	CcSEcCtD
Amitriptyline—Paraesthesia—Mesalazine—Crohn's disease	0.000631	0.00466	CcSEcCtD
Amitriptyline—ABCB1—epithelium—Crohn's disease	0.000626	0.00378	CbGeAlD
Amitriptyline—Somnolence—Mesalazine—Crohn's disease	0.000624	0.00462	CcSEcCtD
Amitriptyline—Dyspepsia—Mesalazine—Crohn's disease	0.000618	0.00457	CcSEcCtD
Amitriptyline—Decreased appetite—Mesalazine—Crohn's disease	0.00061	0.00452	CcSEcCtD
Amitriptyline—Body temperature increased—Azathioprine—Crohn's disease	0.000609	0.00451	CcSEcCtD
Amitriptyline—Fatigue—Mesalazine—Crohn's disease	0.000605	0.00448	CcSEcCtD
Amitriptyline—Erectile dysfunction—Prednisone—Crohn's disease	0.000602	0.00445	CcSEcCtD
Amitriptyline—Constipation—Mesalazine—Crohn's disease	0.000601	0.00444	CcSEcCtD
Amitriptyline—Weight increased—Prednisone—Crohn's disease	0.000595	0.0044	CcSEcCtD
Amitriptyline—Feeling abnormal—Mesalazine—Crohn's disease	0.000579	0.00428	CcSEcCtD
Amitriptyline—Acute coronary syndrome—Prednisone—Crohn's disease	0.000574	0.00425	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Prednisone—Crohn's disease	0.000571	0.00422	CcSEcCtD
Amitriptyline—Myocardial infarction—Prednisone—Crohn's disease	0.000571	0.00422	CcSEcCtD
Amitriptyline—Urticaria—Mesalazine—Crohn's disease	0.000558	0.00413	CcSEcCtD
Amitriptyline—Body temperature increased—Mesalazine—Crohn's disease	0.000555	0.00411	CcSEcCtD
Amitriptyline—ABCB1—mammalian vulva—Crohn's disease	0.000543	0.00328	CbGeAlD
Amitriptyline—Diarrhoea—Azathioprine—Crohn's disease	0.000528	0.0039	CcSEcCtD
Amitriptyline—Hallucination—Prednisone—Crohn's disease	0.00052	0.00385	CcSEcCtD
Amitriptyline—Dizziness—Azathioprine—Crohn's disease	0.00051	0.00377	CcSEcCtD
Amitriptyline—Asthenia—Mesalazine—Crohn's disease	0.000504	0.00373	CcSEcCtD
Amitriptyline—Pruritus—Mesalazine—Crohn's disease	0.000497	0.00368	CcSEcCtD
Amitriptyline—HRH1—lymph node—Crohn's disease	0.000497	0.003	CbGeAlD
Amitriptyline—Vomiting—Azathioprine—Crohn's disease	0.00049	0.00363	CcSEcCtD
Amitriptyline—ADRA2A—lymph node—Crohn's disease	0.000488	0.00295	CbGeAlD
Amitriptyline—Rash—Azathioprine—Crohn's disease	0.000486	0.0036	CcSEcCtD
Amitriptyline—Dermatitis—Azathioprine—Crohn's disease	0.000486	0.00359	CcSEcCtD
Amitriptyline—Headache—Azathioprine—Crohn's disease	0.000483	0.00357	CcSEcCtD
Amitriptyline—ABCB1—lymphoid tissue—Crohn's disease	0.000482	0.00291	CbGeAlD
Amitriptyline—Diarrhoea—Mesalazine—Crohn's disease	0.000481	0.00355	CcSEcCtD
Amitriptyline—Oxcarbazepine—ALB—Crohn's disease	0.00048	0.0953	CrCbGaD
Amitriptyline—ABCB1—digestive system—Crohn's disease	0.000476	0.00288	CbGeAlD
Amitriptyline—Arrhythmia—Prednisone—Crohn's disease	0.000467	0.00346	CcSEcCtD
Amitriptyline—Dizziness—Mesalazine—Crohn's disease	0.000464	0.00344	CcSEcCtD
Amitriptyline—Alopecia—Prednisone—Crohn's disease	0.000462	0.00342	CcSEcCtD
Amitriptyline—Nausea—Azathioprine—Crohn's disease	0.000458	0.00339	CcSEcCtD
Amitriptyline—Vomiting—Mesalazine—Crohn's disease	0.000447	0.0033	CcSEcCtD
Amitriptyline—Rash—Mesalazine—Crohn's disease	0.000443	0.00328	CcSEcCtD
Amitriptyline—Dermatitis—Mesalazine—Crohn's disease	0.000442	0.00327	CcSEcCtD
Amitriptyline—Headache—Mesalazine—Crohn's disease	0.00044	0.00325	CcSEcCtD
Amitriptyline—Vision blurred—Prednisone—Crohn's disease	0.000429	0.00317	CcSEcCtD
Amitriptyline—Ill-defined disorder—Prednisone—Crohn's disease	0.000422	0.00312	CcSEcCtD
Amitriptyline—Agitation—Prednisone—Crohn's disease	0.000418	0.0031	CcSEcCtD
Amitriptyline—Nausea—Mesalazine—Crohn's disease	0.000417	0.00309	CcSEcCtD
Amitriptyline—Malaise—Prednisone—Crohn's disease	0.000411	0.00304	CcSEcCtD
Amitriptyline—Syncope—Prednisone—Crohn's disease	0.000408	0.00302	CcSEcCtD
Amitriptyline—Loss of consciousness—Prednisone—Crohn's disease	0.0004	0.00296	CcSEcCtD
Amitriptyline—Convulsion—Prednisone—Crohn's disease	0.000394	0.00292	CcSEcCtD
Amitriptyline—Hypertension—Prednisone—Crohn's disease	0.000393	0.00291	CcSEcCtD
Amitriptyline—Anxiety—Prednisone—Crohn's disease	0.000386	0.00286	CcSEcCtD
Amitriptyline—Discomfort—Prednisone—Crohn's disease	0.000383	0.00283	CcSEcCtD
Amitriptyline—Oedema—Prednisone—Crohn's disease	0.000372	0.00275	CcSEcCtD
Amitriptyline—Shock—Prednisone—Crohn's disease	0.000366	0.0027	CcSEcCtD
Amitriptyline—Tachycardia—Prednisone—Crohn's disease	0.000363	0.00268	CcSEcCtD
Amitriptyline—Hyperhidrosis—Prednisone—Crohn's disease	0.000359	0.00266	CcSEcCtD
Amitriptyline—Anorexia—Prednisone—Crohn's disease	0.000354	0.00262	CcSEcCtD
Amitriptyline—Thiothixene—ALB—Crohn's disease	0.000349	0.0692	CrCbGaD
Amitriptyline—Insomnia—Prednisone—Crohn's disease	0.000336	0.00249	CcSEcCtD
Amitriptyline—Paraesthesia—Prednisone—Crohn's disease	0.000334	0.00247	CcSEcCtD
Amitriptyline—Dyspepsia—Prednisone—Crohn's disease	0.000327	0.00242	CcSEcCtD
Amitriptyline—Decreased appetite—Prednisone—Crohn's disease	0.000323	0.00239	CcSEcCtD
Amitriptyline—Fatigue—Prednisone—Crohn's disease	0.00032	0.00237	CcSEcCtD
Amitriptyline—Constipation—Prednisone—Crohn's disease	0.000318	0.00235	CcSEcCtD
Amitriptyline—Feeling abnormal—Prednisone—Crohn's disease	0.000306	0.00227	CcSEcCtD
Amitriptyline—Urticaria—Prednisone—Crohn's disease	0.000295	0.00218	CcSEcCtD
Amitriptyline—Body temperature increased—Prednisone—Crohn's disease	0.000294	0.00217	CcSEcCtD
Amitriptyline—Clomipramine—ALB—Crohn's disease	0.000276	0.0547	CrCbGaD
Amitriptyline—ABCB1—lymph node—Crohn's disease	0.000272	0.00164	CbGeAlD
Amitriptyline—Nortriptyline—ALB—Crohn's disease	0.00027	0.0535	CrCbGaD
Amitriptyline—Asthenia—Prednisone—Crohn's disease	0.000267	0.00197	CcSEcCtD
Amitriptyline—Pruritus—Prednisone—Crohn's disease	0.000263	0.00194	CcSEcCtD
Amitriptyline—Diarrhoea—Prednisone—Crohn's disease	0.000254	0.00188	CcSEcCtD
Amitriptyline—Dizziness—Prednisone—Crohn's disease	0.000246	0.00182	CcSEcCtD
Amitriptyline—Vomiting—Prednisone—Crohn's disease	0.000236	0.00175	CcSEcCtD
Amitriptyline—Rash—Prednisone—Crohn's disease	0.000234	0.00173	CcSEcCtD
Amitriptyline—Dermatitis—Prednisone—Crohn's disease	0.000234	0.00173	CcSEcCtD
Amitriptyline—Headache—Prednisone—Crohn's disease	0.000233	0.00172	CcSEcCtD
Amitriptyline—Nausea—Prednisone—Crohn's disease	0.000221	0.00163	CcSEcCtD
Amitriptyline—DRD2—Signaling Pathways—SOCS1—Crohn's disease	1.96e-05	6.73e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—GPCR downstream signaling—CXCL8—Crohn's disease	1.94e-05	6.67e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—RASGRP1—Crohn's disease	1.94e-05	6.65e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling by GPCR—JAK2—Crohn's disease	1.93e-05	6.64e-05	CbGpPWpGaD
Amitriptyline—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	1.93e-05	6.63e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.93e-05	6.62e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	1.93e-05	6.62e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—CXCL8—Crohn's disease	1.93e-05	6.62e-05	CbGpPWpGaD
Amitriptyline—HRH1—GPCR downstream signaling—JAK2—Crohn's disease	1.93e-05	6.62e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—SMAD3—Crohn's disease	1.93e-05	6.62e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—SOCS1—Crohn's disease	1.92e-05	6.61e-05	CbGpPWpGaD
Amitriptyline—CHRM1—GPCR downstream signaling—JAK2—Crohn's disease	1.92e-05	6.6e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—SOCS1—Crohn's disease	1.92e-05	6.59e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—SMAD3—Crohn's disease	1.92e-05	6.58e-05	CbGpPWpGaD
Amitriptyline—CHRM3—GPCR downstream signaling—JAK2—Crohn's disease	1.91e-05	6.58e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—SOCS1—Crohn's disease	1.91e-05	6.57e-05	CbGpPWpGaD
Amitriptyline—CHRM2—GPCR downstream signaling—JAK2—Crohn's disease	1.9e-05	6.51e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—SOCS1—Crohn's disease	1.89e-05	6.5e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	1.89e-05	6.49e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.89e-05	6.49e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	1.89e-05	6.48e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.88e-05	6.46e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—JAK2—Crohn's disease	1.87e-05	6.44e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—TYK2—Crohn's disease	1.87e-05	6.42e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling by GPCR—CXCL8—Crohn's disease	1.85e-05	6.36e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling by GPCR—CXCL8—Crohn's disease	1.84e-05	6.33e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	1.84e-05	6.31e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—SMAD3—Crohn's disease	1.83e-05	6.3e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—TYK2—Crohn's disease	1.83e-05	6.3e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling by GPCR—IL6—Crohn's disease	1.83e-05	6.3e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—TYK2—Crohn's disease	1.83e-05	6.28e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—TYK2—Crohn's disease	1.82e-05	6.26e-05	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—STAT3—Crohn's disease	1.82e-05	6.26e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—TYK2—Crohn's disease	1.8e-05	6.2e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	1.8e-05	6.18e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—FADS1—Crohn's disease	1.79e-05	6.16e-05	CbGpPWpGaD
Amitriptyline—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	1.79e-05	6.15e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.79e-05	6.15e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—IL2RA—Crohn's disease	1.78e-05	6.13e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—JAK2—Crohn's disease	1.78e-05	6.12e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—IL2RA—Crohn's disease	1.77e-05	6.1e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling by GPCR—CXCL8—Crohn's disease	1.76e-05	6.06e-05	CbGpPWpGaD
Amitriptyline—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	1.76e-05	6.05e-05	CbGpPWpGaD
Amitriptyline—HRH1—GPCR downstream signaling—CXCL8—Crohn's disease	1.76e-05	6.04e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.76e-05	6.04e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—GPCR downstream signaling—JAK2—Crohn's disease	1.76e-05	6.03e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—SOCS1—Crohn's disease	1.75e-05	6.02e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	1.75e-05	6.02e-05	CbGpPWpGaD
Amitriptyline—CHRM1—GPCR downstream signaling—CXCL8—Crohn's disease	1.75e-05	6.02e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—JAK2—Crohn's disease	1.75e-05	6.01e-05	CbGpPWpGaD
Amitriptyline—CHRM3—GPCR downstream signaling—CXCL8—Crohn's disease	1.75e-05	6e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—JAK2—Crohn's disease	1.74e-05	5.99e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—JAK2—Crohn's disease	1.74e-05	5.97e-05	CbGpPWpGaD
Amitriptyline—CHRM2—GPCR downstream signaling—CXCL8—Crohn's disease	1.73e-05	5.94e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	1.73e-05	5.93e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—TYK2—Crohn's disease	1.72e-05	5.92e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—JAK2—Crohn's disease	1.72e-05	5.91e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	1.72e-05	5.9e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—CXCL8—Crohn's disease	1.71e-05	5.88e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—IL2RA—Crohn's disease	1.7e-05	5.84e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—TYK2—Crohn's disease	1.7e-05	5.83e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—TYK2—Crohn's disease	1.7e-05	5.83e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—SMAD3—Crohn's disease	1.69e-05	5.81e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.69e-05	5.8e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—TYK2—Crohn's disease	1.68e-05	5.79e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GPX4—Crohn's disease	1.68e-05	5.77e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—TYK2—Crohn's disease	1.67e-05	5.74e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	1.66e-05	5.72e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—SMAD3—Crohn's disease	1.66e-05	5.7e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—SMAD3—Crohn's disease	1.66e-05	5.69e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—SMAD3—Crohn's disease	1.65e-05	5.67e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—TYK2—Crohn's disease	1.65e-05	5.67e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—JAK2—Crohn's disease	1.64e-05	5.65e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—SMAD3—Crohn's disease	1.63e-05	5.61e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	1.63e-05	5.6e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling by GPCR—IL6—Crohn's disease	1.63e-05	5.59e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	1.63e-05	5.59e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GCKR—Crohn's disease	1.62e-05	5.57e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—JAK2—Crohn's disease	1.62e-05	5.56e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—JAK2—Crohn's disease	1.62e-05	5.56e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—JAK2—Crohn's disease	1.61e-05	5.52e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—GPCR downstream signaling—CXCL8—Crohn's disease	1.6e-05	5.51e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—TYK2—Crohn's disease	1.6e-05	5.5e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	1.6e-05	5.5e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—CXCL8—Crohn's disease	1.6e-05	5.49e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—JAK2—Crohn's disease	1.6e-05	5.48e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—CXCL8—Crohn's disease	1.59e-05	5.47e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—CXCL8—Crohn's disease	1.59e-05	5.45e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—JAK2—Crohn's disease	1.57e-05	5.41e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—CXCL8—Crohn's disease	1.57e-05	5.4e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	1.57e-05	5.38e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IL2RA—Crohn's disease	1.57e-05	5.38e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—STAT3—Crohn's disease	1.55e-05	5.32e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	1.54e-05	5.29e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.54e-05	5.28e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IL2RA—Crohn's disease	1.54e-05	5.28e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—TYK2—Crohn's disease	1.53e-05	5.27e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IL2RA—Crohn's disease	1.53e-05	5.27e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—JAK2—Crohn's disease	1.53e-05	5.25e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IL2RA—Crohn's disease	1.53e-05	5.25e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—SMAD3—Crohn's disease	1.51e-05	5.2e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IL2RA—Crohn's disease	1.51e-05	5.2e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	1.51e-05	5.18e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.5e-05	5.16e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—CXCL8—Crohn's disease	1.5e-05	5.15e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—CXCL8—Crohn's disease	1.48e-05	5.08e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—CXCL8—Crohn's disease	1.48e-05	5.07e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—CXCL8—Crohn's disease	1.47e-05	5.04e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—JAK2—Crohn's disease	1.46e-05	5.03e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—TYK2—Crohn's disease	1.46e-05	5e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—CXCL8—Crohn's disease	1.46e-05	5e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—TYK2—Crohn's disease	1.44e-05	4.95e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—TYK2—Crohn's disease	1.44e-05	4.95e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—CXCL8—Crohn's disease	1.44e-05	4.93e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling by GPCR—IL6—Crohn's disease	1.43e-05	4.9e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling by GPCR—IL6—Crohn's disease	1.41e-05	4.83e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling by GPCR—IL6—Crohn's disease	1.4e-05	4.82e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IL2RA—Crohn's disease	1.4e-05	4.82e-05	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—IL6—Crohn's disease	1.4e-05	4.8e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling by GPCR—IL6—Crohn's disease	1.4e-05	4.79e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—CXCL8—Crohn's disease	1.39e-05	4.79e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—JAK2—Crohn's disease	1.39e-05	4.77e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—STAT3—Crohn's disease	1.38e-05	4.73e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—JAK2—Crohn's disease	1.38e-05	4.73e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—JAK2—Crohn's disease	1.38e-05	4.73e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling by GPCR—IL6—Crohn's disease	1.37e-05	4.69e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—CXCL8—Crohn's disease	1.34e-05	4.59e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling by GPCR—IL6—Crohn's disease	1.33e-05	4.55e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—ALB—Crohn's disease	1.32e-05	4.54e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.31e-05	4.52e-05	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—IL6—Crohn's disease	1.27e-05	4.37e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling by GPCR—IL6—Crohn's disease	1.27e-05	4.36e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—CXCL8—Crohn's disease	1.27e-05	4.35e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TYK2—Crohn's disease	1.26e-05	4.32e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—CXCL8—Crohn's disease	1.26e-05	4.31e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—CXCL8—Crohn's disease	1.26e-05	4.31e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TYK2—Crohn's disease	1.25e-05	4.29e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—ALB—Crohn's disease	1.21e-05	4.16e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—STAT3—Crohn's disease	1.21e-05	4.14e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling by GPCR—IL6—Crohn's disease	1.21e-05	4.14e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—JAK2—Crohn's disease	1.2e-05	4.12e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TYK2—Crohn's disease	1.2e-05	4.11e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling by GPCR—IL6—Crohn's disease	1.19e-05	4.1e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling by GPCR—IL6—Crohn's disease	1.19e-05	4.1e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—JAK2—Crohn's disease	1.19e-05	4.1e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—STAT3—Crohn's disease	1.19e-05	4.08e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—STAT3—Crohn's disease	1.19e-05	4.08e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—STAT3—Crohn's disease	1.18e-05	4.05e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—PTGS2—Crohn's disease	1.16e-05	3.97e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—STAT3—Crohn's disease	1.16e-05	3.97e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—JAK2—Crohn's disease	1.14e-05	3.92e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—ALB—Crohn's disease	1.14e-05	3.9e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—STAT3—Crohn's disease	1.12e-05	3.85e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—ALB—Crohn's disease	1.11e-05	3.82e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—ALB—Crohn's disease	1.11e-05	3.82e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TYK2—Crohn's disease	1.1e-05	3.79e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—CXCL8—Crohn's disease	1.09e-05	3.76e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—CXCL8—Crohn's disease	1.09e-05	3.74e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TYK2—Crohn's disease	1.09e-05	3.73e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TYK2—Crohn's disease	1.08e-05	3.72e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—IL6—Crohn's disease	1.08e-05	3.72e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TYK2—Crohn's disease	1.08e-05	3.71e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TYK2—Crohn's disease	1.08e-05	3.7e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—STAT3—Crohn's disease	1.07e-05	3.69e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TYK2—Crohn's disease	1.07e-05	3.66e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	1.06e-05	3.65e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—PTGS2—Crohn's disease	1.06e-05	3.64e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—JAK2—Crohn's disease	1.05e-05	3.62e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—CXCL8—Crohn's disease	1.04e-05	3.58e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling by GPCR—IL6—Crohn's disease	1.04e-05	3.57e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—JAK2—Crohn's disease	1.04e-05	3.56e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling by GPCR—IL6—Crohn's disease	1.04e-05	3.56e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—JAK2—Crohn's disease	1.03e-05	3.55e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—JAK2—Crohn's disease	1.03e-05	3.54e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—JAK2—Crohn's disease	1.03e-05	3.53e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—STAT3—Crohn's disease	1.02e-05	3.5e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—JAK2—Crohn's disease	1.02e-05	3.49e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	1.01e-05	3.48e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—STAT3—Crohn's disease	1.01e-05	3.47e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—STAT3—Crohn's disease	1.01e-05	3.47e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—PTGS2—Crohn's disease	9.94e-06	3.42e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling by GPCR—IL6—Crohn's disease	9.91e-06	3.4e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TYK2—Crohn's disease	9.88e-06	3.39e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PTGS2—Crohn's disease	9.74e-06	3.35e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PTGS2—Crohn's disease	9.72e-06	3.34e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—ALB—Crohn's disease	9.62e-06	3.31e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—IL6—Crohn's disease	9.61e-06	3.3e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CXCL8—Crohn's disease	9.61e-06	3.3e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	9.45e-06	3.25e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CXCL8—Crohn's disease	9.43e-06	3.24e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—JAK2—Crohn's disease	9.42e-06	3.24e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CXCL8—Crohn's disease	9.4e-06	3.23e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CXCL8—Crohn's disease	9.37e-06	3.22e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CXCL8—Crohn's disease	9.28e-06	3.19e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	9.26e-06	3.18e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—IL6—Crohn's disease	9.14e-06	3.14e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—IL6—Crohn's disease	8.99e-06	3.09e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—IL6—Crohn's disease	8.97e-06	3.08e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—IL6—Crohn's disease	8.94e-06	3.07e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—IL6—Crohn's disease	8.91e-06	3.06e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—IL6—Crohn's disease	8.83e-06	3.03e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	8.8e-06	3.02e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—STAT3—Crohn's disease	8.8e-06	3.02e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—STAT3—Crohn's disease	8.75e-06	3.01e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CXCL8—Crohn's disease	8.6e-06	2.95e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—ALB—Crohn's disease	8.59e-06	2.95e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—IL6—Crohn's disease	8.43e-06	2.89e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PTGS2—Crohn's disease	8.42e-06	2.89e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—ALB—Crohn's disease	8.38e-06	2.88e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—STAT3—Crohn's disease	8.38e-06	2.88e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PTGS2—Crohn's disease	8.37e-06	2.88e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—IL6—Crohn's disease	8.3e-06	2.85e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—IL6—Crohn's disease	8.29e-06	2.85e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—IL6—Crohn's disease	8.24e-06	2.83e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—IL6—Crohn's disease	8.18e-06	2.81e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—IL6—Crohn's disease	8.07e-06	2.77e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—ALB—Crohn's disease	7.9e-06	2.71e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—IL6—Crohn's disease	7.83e-06	2.69e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—ALB—Crohn's disease	7.83e-06	2.69e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—STAT3—Crohn's disease	7.73e-06	2.65e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—STAT3—Crohn's disease	7.6e-06	2.61e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—STAT3—Crohn's disease	7.59e-06	2.61e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—STAT3—Crohn's disease	7.56e-06	2.6e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—STAT3—Crohn's disease	7.54e-06	2.59e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PTGS2—Crohn's disease	7.51e-06	2.58e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—IL6—Crohn's disease	7.5e-06	2.58e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—STAT3—Crohn's disease	7.46e-06	2.56e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	7.44e-06	2.56e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PTGS2—Crohn's disease	7.33e-06	2.52e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—IL6—Crohn's disease	7.12e-06	2.45e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—IL6—Crohn's disease	7.05e-06	2.42e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—IL6—Crohn's disease	7.05e-06	2.42e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—STAT3—Crohn's disease	6.92e-06	2.38e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PTGS2—Crohn's disease	6.91e-06	2.37e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PTGS2—Crohn's disease	6.85e-06	2.35e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—ALB—Crohn's disease	6.69e-06	2.3e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—IL6—Crohn's disease	6.15e-06	2.11e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—IL6—Crohn's disease	6.12e-06	2.1e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PTGS2—Crohn's disease	5.85e-06	2.01e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—IL6—Crohn's disease	5.85e-06	2.01e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IL6—Crohn's disease	5.4e-06	1.85e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IL6—Crohn's disease	5.31e-06	1.82e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IL6—Crohn's disease	5.3e-06	1.82e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IL6—Crohn's disease	5.28e-06	1.81e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IL6—Crohn's disease	5.27e-06	1.81e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IL6—Crohn's disease	5.21e-06	1.79e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IL6—Crohn's disease	5.2e-06	1.79e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—ALB—Crohn's disease	5.16e-06	1.77e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IL6—Crohn's disease	4.83e-06	1.66e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PTGS2—Crohn's disease	4.52e-06	1.55e-05	CbGpPWpGaD
